Corticosteroids use can cause raised intraocular pressure (IOP), leading to glaucoma. We present a case report of steroid induced glaucoma in a young male with keratoconjunctivitis (VKC). Our patient was uncompliant with instructions to stop steroid use, initially started for VKC treatment, and required aggressive medical and surgical intervention for IOP control. He eventually progressed to severe glaucomatous optic neuropathy and eventual tunnel vision. Steroid induced glaucoma is an important and frequently encountered condition in ophthalmology clinics. This report serves to remind all physicians of the dangers of steroid eye drop usage.
BieloryBPPerezVLBieloryL. Treatment of allergic conjunctivitis with ophthalmic corticosteroids: In search of the perfect ocular corticosteroid in the treatment of allergic conjunctivitis. Curr Opin Allergy Clin Immunol2010;10(5):469–77.
3.
ButcherJMAustinMMcGalliardJBourkeRD. Bilateral cataracts and glaucoma induced by long term use of steroid eye drops. BMJ1994;309(6946):43.
4.
WilenskyJT. The role of diurnal pressure measurements in the management of open angle glaucoma. Curr Opin Ophthalmol2004;15(2):90–2.
5.
OnoSJAbelsonMB. Allergic conjunctivitis: Update on pathophysiology and prospects for future treatment. J Allergy Clin Immunol2005;115(1):118–22.
6.
KumarS. Vernal keratoconjunctivitis: A major review. Acta Ophthalmol2009;87(2):133–47.
7.
CarnahanMCGoldsteinDA. Ocular complications of topical, peri-ocular, and systemic corticosteroids. Curr Opin Ophthalmol2000;11(6):478–83.
8.
WordingerRJClarkAF. Effects of glucocorticoids on the trabecular meshwork: Towards a better understanding of glaucoma. Prog Retina Eye Res1999;18(5):629–67.
9.
ClarkAFBrotchieDReadATHellbergPEnglish-WrightSPangIH. Dexamethasone alters F-actin architecture and promotes cross-linked actin network formation in human trabecular meshwork tissue. Cell Motil Cytoskeleton2005;60(2):83–95.
10.
SmithenLMOberMDMarananLSpaideRF. Intravitreal triamcinolone acetonide and intraocular pressure. Am J Ophthalmol2004;138(5):740–3.
11.
CubeyRB. Glaucoma following the application of corticosteroid to the skin of the eyelids. Br J Dermatol1976;95:207–8.
12.
ArmalyMF. Effect of corticosteroids on intraocular pressure and fluid dynamics: I. The effect of dexamethasone in the normal eye. Arch Ophthalmol1963;70:482–91.
13.
ArmalyMF. Effect of corticosteroids on intraocular pressure and fluid dynamics: II. The effect of dexamethasone on the glaucomatous eye. Arch Ophthalmol1963 Oct;70:492–9.
14.
BeckerBMillsDW. Corticosteroids and intraocular pressure. Arch Ophthalmol1963;70(4):500–7.
15.
BeckerBHahnKA. Topical corticosteroids and heredity in primary open-angle glaucoma. Am J Ophthalmol1964;54:543–51.
16.
LamDSFanDSNgJSYuCBWongCYCheungAY. Ocular hypertensive and anti-inflammatory responses to different dosages of topical dexamethasone in children: A randomized trial. Clin Exp Ophthalmol2005;33(3):252–8.
17.
GatsonHAbsolonMJThurtleOASattarMA. Steroid responsiveness in connective tissue diseases. Br J Ophthalmol1983;67(7):487–90.
18.
XuLWangYWangSWangYJonasJB. High myopia and glaucoma susceptibility the Beijing Eye Study. Ophthalmology2007;114(2):216–20.
19.
WeinrebRNPolanskyJRKramerSGBaxterJD. Acute effects of dexamethasone on intraocular pressure in glaucoma. Invest Ophthalmol Vis Sci1985;26(2):170–5.
20.
JonasJBKreissigIDegenringR. Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol2003;87(1):24–7.
21.
TsaiCSShinDHWanJYZeiterJH. Visual field global indices in patients with reversal of glaucomatous cupping after intraocular pressure reduction. Ophthalmology1991;98(9):1412–9.
22.
FrankelM. Blindness due to steroid induced glaucoma. IMJ III Med J1969;135(2):160–3.
23.
HeZBuiVBVingryAJ. The rate of functional recovery from acute IOP elevation. Invest Ophthalmol Vis Sci2006;47(11):4872–80.
24.
AsraniSZeimerRWilenskyJGieserDVitaleSLindenmuthK. Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma2000;9(2):134–42.
25.
CaprioliJColemanAL. A risk factor for visual field progression at low intraocular pressures in the Advanced Glaucoma Intervention Study. Ophthalmology2008;115(7):1123–9.
26.
Prevalence and determinants of non-adherence to topical hypotensive treatment in Dutch glaucoma patients. Graefes Arch Clin Exp Ophthalmol2009;247(2):235–43.
27.
CreweJMMorletNMorganWHSpilsburyKMukhtarAClarkA. Quality of life of the most severely vision-impaired. Clin Experiment Ophthalmol2011;39(4):336–43.
28.
Tunde-AyinmodeMFAkandeTMAdemola-PopoolaDS. Psychological and social adjustment to blindness: Understanding from two groups of blind people in Ilorin, Nigeria. Ann Afr Med2011;10(2):155–64.
